Investigational Ointment Improves Eczema
LOS ANGELES — Crisaborole, a topical phosphodiesterase 4 inhibitor, improved the symptoms of mild to moderate eczema in two phase 3 safety and efficacy trials. This new drug, if approved, could be used as an alternative to steroids and calcineurin …
Read more on Medscape

Flint residents fight lead's effects on hair, skin
While claims of hair loss and dry skin patches have been reported, Dr. Walter Barkey, a dermatologist in the Flint area, said some of Flint's struggling residents may not be seeking treatment. “I have seen the regular cases of eczema, but what you have …
Read more on The Detroit News

The Zacks Analyst Blog Highlights: Gilead, Regeneron, Medivation and Intercept
Chicago, IL – April 07, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in …
Read more on Yahoo News